Tesamorelin (Egrifta/Egrifta SV) is a synthetic GHRH analogue and the only FDA-approved growth hormone-releasing hormone analogue currently marketed in the United States, indicated for visceral fat reduction in HIV-positive patients with lipodystrophy [2], [5]
Once inside adipocytes and other metabolically active cells, the compound binds to the NNMT active site, preventing the enzyme from converting nicotinamide to 1-MNA
They support red blood cell production, DNA synthesis, and normal nerve function when deficiency is present
Imagine the potential for significant weight loss with this powerful tool in your weight loss journey
Revitalize your health with Cyanocobalamin Injection 1000 mcg/mL by Lifestar Pharma, a potent and reliable solution for Vitamin B12 deficiency
Because of this targeted structure, it is discussed in research in the context of fat metabolism rather than the broader effects of full growth hormone